Technical Analysis with a Quantitative Edge

SIGN UP  |  LOGIN

HOW IT WORKS    TRADE SIGNALS    SCREENER    MY PORTFOLIO    HELP

Merrimack Pharmaceuticals, Inc. (MACK)
Equity - Health Care - Major Pharmaceuticals

 

As of 2017-06-27

Add to My Portfolio
Close1.27Open1.31
Prev Close1.30Daily Chg-0.03 (-2.31%)
High1.32Volume1,639,880
Low1.2652-Week High/Low6.68 / 1.16
Dividend Yield0%Curr P/EN/A
Curr Year EPS Est-0.54Fwd P/EN/A
P/BN/AShort Ratio8.43
P/S1.19PEG Ratio-0.48
Latest QuantForecast
As Of
Customize QuantForecast   View Commentary & Pattern   Save To My Forecasts     Share

 
 
 

SUPPORT
Lower Boll Band: 1.07
RESISTANCE
9EMA: 1.33 20SMA: 1.38 Upper Boll Band: 1.69
COMMENTARY
Strong downtrend across all timeframes . Near-term technicals are oversold with RSI near historical low. Forecast suggests sideways consolidation with choppy action
TECHNICAL PATTERN

TYPEDESCRIPTION (?)CRITERIA (?)
Oversold Condition RSI near historical low at 28.51, occurred 4.44% of the time RSI = 28.51 +- 0.44
FORECAST STATISTICS
TIMEFRAME 2-DAY 5-DAY 10-DAY 20-DAY
Average -1.41% -3.41% +0.62% +2.10%
Best +6.00% +4.67% +22.94% +19.42%
Worst -10.35% -16.89% -21.05% -17.37%
% Positive 43% 57% 71% 57%
Outlook NEUTRAL NEUTRAL BULLISH NEUTRAL
HISTORICAL MATCHES (?)
MATCH DATE 2-DAY 5-DAY 10-DAY 20-DAY
2017-06-27 0% 0% 0% 0%
2017-01-26 +1.32% +0.99% +6.95% -0.33%
2017-01-09 -10.35% -16.89% -15.53% -12.26%
2017-01-05 -3.42% -13.95% -21.05% -17.37%
2015-07-21 +6.00% +4.67% +6.10% +6.91%
2014-07-17 +0.51% +0.51% +0.68% +19.42%
2013-08-23 -0.88% -0.59% +22.94% +11.76%
2012-10-23 -3.05% +1.37% +4.27% +6.55%
# Matches 7
TRADE SIGNALS ?
POSITIONENTRY DATEENTRY PRICETARGET PRICE (?)STOP PRICE (?)CURRENT PNL %
Premium Members Only

Upgrade Now & Subscribe to Daily Trade Signals

CLOSED TRADES
POSITIONENTRY DATEENTRY PRICEEXIT DATE EXIT PRICEREALIZED PNL %
Short 2016-03-21 8.30 2016-04-28 7.29 +12.17%
Long 2014-04-29 4.49 2014-05-08 6.38 +42.09%
Related Stocks
SYMBOL NAME Close VOLUME CHG WTD MTD YTD QUANTFORECAST(?)
2-DAY 5-DAY 10-DAY 20-DAY
JNJ Johnson & Johnson 135.04 5,060,952 -1.33 (-0.98%) -1.36 (-1.00%) +6.82 (+5.32%) +20.58 (+17.98%)
PFE Pfizer, Inc. 33.78 12,782,325 -0.27 (-0.79%) -0.38 (-1.11%) +1.13 (+3.46%) +1.93 (+6.07%)
MRK Merck & Company, Inc. 65.56 6,882,359 -0.35 (-0.54%) -0.60 (-0.91%) +0.45 (+0.68%) +7.11 (+12.17%)
SNY Sanofi 49.35 602,184 -0.33 (-0.66%) +0.03 (+0.06%) -0.24 (-0.48%) +8.91 (+22.03%)
ABBV AbbVie Inc. 72.41 4,003,483 -0.31 (-0.43%) -0.24 (-0.33%) +6.36 (+9.63%) +11.05 (+18.01%)
>>> See More Related Stocks
LATEST BUZZ
@RightKindaGuy
Posted 2017-06-28T15:29:24Z
$MACK And suddenly, my 1.41 avg doesnt look too bad
@Obelix
Posted 2017-06-28T15:27:38Z
$MACK back to the 5's XD
@quanmunist
Posted 2017-06-28T15:14:58Z
$MACK go up with $ibb. Break 1.50 this time!
@Bati
Posted 2017-06-28T14:56:03Z
$MACK Nice volume
@Kevin_Wolcott
Posted 2017-06-28T14:40:13Z
$MACK Even shorts are bored here. They covered a little this morning. Back to dead meat zone please
@trader0607
Posted 2017-06-28T14:29:23Z
$MACK in
@Leader2light
Posted 2017-06-28T14:26:24Z
$MACK loaded up more yesterday. Under 2$ avg now. Yahhhh. Steal at these levels. 1 hit 2018 see 5$
@kingscats
Posted 2017-06-28T14:24:06Z
$MACK I was away for 3 days and what do I see here - hmmm - no reversal to the 2.50's!
@edomando
Posted 2017-06-28T14:20:57Z
$MACK Nice 👍
@socnet
Posted 2017-06-28T14:20:19Z
Highlights on $MACK, $MNKD, $GLYC, $RDUS http://crweworld.com/newsroom/prnewswire?rkey=20170628enUK201706286828&filter=10284
@bmoney91
Posted 2017-06-28T14:19:58Z
$MACK is BACK
@Irisheye
Posted 2017-06-28T14:18:00Z
$MACK awakening ?
@deathbybiopharma
Posted 2017-06-28T14:16:49Z
$MACK lol for fucks sake I knew it
@Bati
Posted 2017-06-28T14:14:46Z
$MACK going to 1.60 first step
@TheBee
Posted 2017-06-28T14:13:03Z
$MACK so far so good
@biokb1234
Posted 2017-06-28T14:08:06Z
$MACK resistance 1.36
@nkeaandy
Posted 2017-06-28T14:04:05Z
$MACK Don't play with my feelings.
@rocketrades
Posted 2017-06-28T13:59:53Z
$MACK 1.35
@scalesojustice
Posted 2017-06-28T13:58:03Z
$MACK Management should be looking very hard at an LBO
@MisterBroGuy
Posted 2017-06-28T13:57:57Z
$MACK don't tease me bro
MACK LATEST NEWS
These 3 Biotechs Have Been Crushed; Is It Time to Bargain Shop?
Posted Wed, 21 Jun 2017 21:23:17 Z
It looks like an especially cruel summer lies ahead for XBiotech Inc NASDAQ XBIT Merrimack Pharmaceuticals Inc NASDAQ MACK and NewLink Genetics Corp NASDAQ NLNK The market has already dragged these biotechs out behind the tool shed and spent a few months... >>> Read More
Merrimack Completes Enrollment in Phase II Study for MM-141
Posted Tue, 20 Jun 2017 16:23:05 Z
Merrimack Pharmaceuticals Inc MACK announced completion of enrollment in the ongoing phase II study CARRIE evaluating its pipeline candidate MM 141 istiratumab in combination with standard of care for treatment of patients with previously untreated metastatic pancreatic cancer In... >>> Read More
Why Is Merrimack (MACK) Down 57.6% Since the Last Earnings Report?
Posted Wed, 14 Jun 2017 10:06:33 Z
It has been about a month since the last earnings report for Merrimack Pharmaceuticals Inc MACK Shares have lost about 57 6 in that time frame underperforming the market Will the recent negative trend continue leading up to the stock s next earnings release or is it due for a... >>> Read More
Gainers & Losers Of June 1: XBIT, CBMG, COLL, NEOT, MACK...
Posted Thu, 01 Jun 2017 22:49:00 Z
Gainers & Losers Of June 1: XBIT, CBMG, COLL, NEOT, MACK...... >>> Read More
Why iRobot, Golar LNG, and Merrimack Pharmaceuticals Slumped Today
Posted Wed, 31 May 2017 23:33:35 Z
The market has seen an unusual lack of volatility lately and Wednesday continued the trend with major benchmarks falling less than 0 15 The Dow managed to hold onto the 21 000 mark as uncertainty about the future of the U S economy seemed to prevent the stock market... >>> Read More

WINGCHARTS.COM    HOW IT WORKS    TRADE SIGNALS    SCREENER    MY PORTFOLIO    HELP

 



Follow Us on StockTwits
Partners / Affiliates

Copyright © 2017 WingCapital Co., Ltd. All Rights Reserved.

Disclaimer: Past results are not necessarily indicative of future performance. This website is for educational purposes only. No content published in this website, services and products constitutes a recommendation that any particular investment, security, portfolio of securities, transaction or investment strategy is suitable for any specific person. Practical use of the content, forecasts, charts and services provided in this website are at your own risk and WingCapital Co., Ltd., WingCharts.com, its partners, representatives and employees assume no responsibility or liability for any use of the website. Please contact your financial advisor for specific financial advice tailored to your personal circumstances. Trade signals shown are hypothetical and do not represent actual trades. Actual results may differ. Views, forecasts and commentaries expressed in this website are WingCapital Co., Ltd.'s own opinions, and are not guarantees of future performance, and are subject to change over time.

WingCharts.com and WingCapital Co., Ltd. are not registered investment advisor or a broker dealer and do not give individualized market advice. The information on this website is for illustration purposes only and should not be considered as a solicitation of an offer on the purchase or sale of any securities. Trading in the securities markets involves substantial risk and should not be undertaken without due diligence and serious independent study. WingCapital Co., Ltd. recommends consulting a licensed professional broker regarding your personal investments. Without limitation, WingCapital Co., Ltd. shall not be responsible or liable for any loss or damages related to, either directly or indirectly, (1) any decline in market value or loss of any investment; (2) a subscribers inability to use or any delay in accessing the WingCharts.com website or any other source of material provided by WingCharts.com and WingCapital Co., Ltd.; (3) any absence or error of material on WingCharts.com website or presentation; (4) WingCapital Co., Ltd. failure to deliver or delay in delivering any material or (5) any kind of error in transmission of material.

ALL INFORMATION AND MATERIALS ARE PROVIDED "AS IS", WITHOUT WARRANTY OF ANY KIND, EITHER EXPRESSED OR IMPLIED, INCLUDING, WITHOUT LIMITATION ANY WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE.